Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EUnetHTA project plan for the assessment of 3D printed implants has been released

This project is authored by the Danish Social & Health Services and Labour Market (DEFACTUM). The co-author is the Basque Office for Health Technology Assessment (OSTEBA), with four other HTA agencies from all over Europe (Belgium, Croatia, Hungary and Austria) being dedicated reviewers.

The HTA Core Model Application for Rapid Relative Effectiveness Assessments (REA, v 4.2) will be followed for the selection of assessment elements. Manufacturers will also be asked to provide non-confidential evidence with a focus on the technical characteristics and current use of the technology.

This rapid assessment is planned to be published on April 19, 2019.

The full project plan can be seen in English here.

EUnetHTA also published the external expert and manufacturer comments, which could be found in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.